GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
316 hedge funds and large institutions have $2.86B invested in GW Pharmaceuticals Plc American Depositary Shares in 2019 Q3 according to their latest regulatory filings, with 50 funds opening new positions, 103 increasing their positions, 82 reducing their positions, and 51 closing their positions.
61% more call options, than puts
Call options by funds: $256M | Put options by funds: $159M
26% more repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 82
1% less funds holding
Funds holding: 318 → 316 (-2)
2% less first-time investments, than exits
New positions opened: 50 | Existing positions closed: 51
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
34% less capital invested
Capital invested by funds: $4.35B → $2.86B (-$1.49B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$130M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$84.2M |
| 3 |
Morgan Stanley
New York
|
+$48.4M |
| 4 |
Renaissance Technologies
New York
|
+$45.5M |
| 5 |
Holocene Advisors
New York
|
+$39.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$268M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$77.4M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$57.5M |
| 4 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$36.7M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$33.8M |
GWPH Hedge Fund Activity: Q3 2019 in Review
316 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2019, worth a combined $2.86B — down 34% from $4.35B a quarter earlier.
Sellers outnumbered buyers: 51 funds closed out of GWPH and 50 opened new positions — a net loss of 1 holder — while 82 trimmed existing stakes and 103 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $130M. The largest seller was Capital World Investors, cutting an estimated $268M.
- 316 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2019, down from 318 in Q2 2019.
- Funds reported $2.86B of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2019, down 34% quarter-over-quarter.
- 50 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2019 and 51 closed out, a net change of -1 holder.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2019 was Millennium Management, an estimated $130M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2019 was Capital World Investors, an estimated $268M sold.
Based on aggregated 13F filings for Q3 2019.